Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

UVIMAG

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Pharmaceutical drug in Italy. The asset is a drinkable ampoule drug indicated for magnesium deficiencies.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
G2D Pharma
Primary Office
  • Italy

UVIMAG Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore UVIMAG‘s full profile, request access.

Request full access to PitchBook

UVIMAG Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore UVIMAG‘s full profile, request access.

Request full access to PitchBook